Mr. Anthony (Tony) P. Bihl III, currently serves as interim Chief Executive Officer of Bioventus LLC. He will also serve on the company’s Board of Managers. Mr. Bihl served as CEO and member of the Board of Managers of Bioventus LLC from 2013 until his retirement in 2020. Mr. Bihl is a seasoned executive with more than 35 years of proven industry experience and currently serves as a board member for Sonendo Inc. and Spectral Medical Inc.
Bihl previously served as CEO and President of American Medical Systems (AMS), a publicly traded diversified supplier of medical devices and pelvic procedures. During his four years with the company, he led its restructuring following a series of acquisitions, strengthened its management team, established a performance-based culture with clear accountability, and achieved revenue growth and grew operating profit. In 2011, Bihl led the company to its successful sale to Endo Pharmaceuticals.
Prior to AMS, Bihl was CEO of Siemens Medical Solutions Diagnostics, a $2.5 billion division of Siemens AG focused on the in vitro diagnostics (IVD) market. There, he led the formation of the division by successfully integrating two business units involving more than 8,000 employees and operations in 100 countries – all while achieving sales growth faster than market growth and exceeding profit targets.
Bihl also served as President of the $1.8 billion diagnostics division of Bayer Healthcare LLC, and as Executive Vice President for Bayer Healthcare LLC. He consistently grew sales for the division and managed the strategic discussions and due diligence that resulted in the division’s acquisition by Siemens for $5.4 billion.
Before joining Bayer, Bihl held management positions at Sterling Diagnostic Imaging and E.I. DuPont.
He holds a Bachelor of Science with distinction degree from Pennsylvania State University.
What is P Bihl III's net worth?
The estimated net worth of P Bihl III is at least $1.05 million as of August 18th, 2023. III owns 138,290 shares of Bioventus stock worth more than $1,053,770 as of December 5th. This net worth estimate does not reflect any other assets that III may own. Learn More about P Bihl III's net worth.
How do I contact P Bihl III?
Has P Bihl III been buying or selling shares of Bioventus?
P Bihl III has not been actively trading shares of Bioventus during the past quarter. Most recently, on Friday, August 18th, Anthony P. Bihl III bought 13,290 shares of Bioventus stock. The stock was acquired at an average cost of $4.14 per share, with a total value of $55,020.60. Following the completion of the transaction, the chief executive officer now directly owns 138,290 shares of the company's stock, valued at $572,520.60. Learn More on P Bihl III's trading history.
Who are Bioventus' active insiders?
Are insiders buying or selling shares of Bioventus?
In the last twelve months, insiders at the sold shares 10 times. They sold a total of 83,963 shares worth more than $759,143.60. The most recent insider tranaction occured on November, 7th when Director Michelle Mcmurry-Heath sold 17,701 shares worth more than $131,341.42. Insiders at Bioventus own 33.0% of the company.
Learn More about insider trades at Bioventus. Information on this page was last updated on 11/7/2025.
